{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T06:03:43Z","timestamp":1791525823422,"version":"4.3.4"},"reference-count":24,"publisher":"Georg Thieme Verlag KG","issue":"09","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rofo"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Online survey about the current status of CT protocols in hepatocellular carcinoma (HCC) in the year 2023\/2024. Moreover, the usage of structured reporting using LI-RADS and mRECIST was surveyed and the results were compared with a survey from 2020.<\/jats:p><jats:p>Radiologists working in outpatient or inpatient care in Germany were invited. The survey was conducted between 10\/2022 and 06\/2023 and between 06\/2024 and 08\/2024. HCC-related questions were asked regarding the commonly used imaging modalities, body coverage, and contrast phases in CT, as well as the usage of structured assessment and treatment response using mRECIST and LI-RADS.<\/jats:p><jats:p>More than half of the participants stated that they \u201cfrequently\u201d perform imaging of HCC. In the CT protocol, acquisition of a pre-contrast phase was widespread. While a late arterial and a portal venous contrast phase was acquired in most cases, a delayed phase was used much less frequently (at small and medium-sized hospitals only in 26.5%). For staging, LI-RADS was used in structured reports in only 13%; for response monitoring mRECIST was used at university hospitals in only 26.5% and LI-RADS in 14.7%, whereas these have been almost never used in routine practice at all other sites. The main reasons given for the lack of application were the expenditure of time, the lack of reporting templates, problems with integration into the IT infrastructure and a lack of reimbursement.<\/jats:p><jats:p>The recommendation of a three phase CT examination in late arterial, portal venous, and delayed phase for HCC diagnostics according to LI-RADS is only partially implemented in Germany. Structured reporting for staging and response monitoring using LI-RADS and mRECIST was at a similarly low level in Germany in 2023 compared to 2020. Possible solutions include the development and distribution of online educational resources, structured reporting templates, and inexpensive IT solutions.<\/jats:p>","DOI":"10.1055\/a-2438-1670","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T18:33:32Z","timestamp":1737657212000},"page":"1043-1056","source":"Crossref","is-referenced-by-count":3,"title":["Standardized Reporting of HCC with LI-RADS and mRECIST: Update on the Situation in Germany"],"prefix":"10.1055","volume":"197","author":[{"given":"Christian","family":"Nelles","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and University Hospital Cologne, Department of Diagnostic and Interventional Radiology, University Hospital Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3032-2321","authenticated-orcid":false,"given":"Inka","family":"Ristow","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus S","family":"Juchems","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology, Klinikum Konstanz, Konstanz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Wessling","sequence":"additional","affiliation":[{"name":"Department of Radiology, Clemenshospital GmbH Munster, Munster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0315-135X","authenticated-orcid":false,"given":"Kristina Imeen","family":"Ringe","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0833-8538","authenticated-orcid":false,"given":"Ana","family":"Fehrmann-Efferoth","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and University Hospital Cologne, Department of Diagnostic and Interventional Radiology, University Hospital Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Lennartz","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and University Hospital Cologne, Department of Diagnostic and Interventional Radiology, University Hospital Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saif","family":"Afat","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology, Eberhard Karls University T\u00fcbingen Faculty of Medicine, Tubingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Othman","sequence":"additional","affiliation":[{"name":"Department of Neuroradiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Eisenbl\u00e4tter","sequence":"additional","affiliation":[{"name":"Dept. of Diagnostic & Interventional Radiology, University Hospital OWL of Bielefeld University Campus Hospital Lippe, Detmold, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Paul","sequence":"additional","affiliation":[{"name":"Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"Gerwing","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology, University Hospital Marburg, Marburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5928-4405","authenticated-orcid":false,"given":"Thorsten","family":"Persigehl","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and University Hospital Cologne, Department of Diagnostic and Interventional Radiology, University Hospital Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2025,1,23]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1097\/MCG.0b013e3182872f29","article-title":"Epidemiology of HCC: Consider the Population","volume":"47","author":"S Mittal","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"68","author":"JA Marrero","year":"2018","journal-title":"Hepatology"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: Trends, risk, prevention and management","volume":"16","author":"JD Yang","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"S 02","key":"ref4","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.1111\/j.1872-034X.2007.00168.x","article-title":"Epidemiology of hepatocellular carcinoma in USA","volume":"37","author":"HB El-Serag","year":"2007","journal-title":"Hepatol Res"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/hep.22312","article-title":"Trends in mortality from hepatocellular carcinoma in Europe, 1980\u20132004","volume":"48","author":"C Bosetti","year":"2008","journal-title":"Hepatology"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bpg.2004.10.004","article-title":"Epidemiology and natural history of hepatocellular carcinoma","volume":"19","author":"KA McGlynn","year":"2005","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1055\/s-0030-1247133","article-title":"Current strategy for staging and treatment: The BCLC update and future prospects","volume":"30","author":"A Forner","year":"2010","journal-title":"Semin Liver Dis"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"JK Heimbach","year":"2018","journal-title":"Hepatology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00261-017-1228-y","article-title":"LI-RADS\u00ae algorithm: CT and MRI","volume":"43","author":"V Chernyak","year":"2018","journal-title":"Abdom Radiol (NY)"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/PAP.0000000000000089","article-title":"Update on the Liver Imaging Reporting and Data System: What the Pathologist Needs to Know","volume":"22","author":"A Tang","year":"2015","journal-title":"Adv Anat Pathol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1148\/radiol.2018181494","article-title":"Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients","volume":"289","author":"V Chernyak","year":"2018","journal-title":"Radiology"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.jacr.2017.02.050","article-title":"Impact of a Structured Report Template on the Quality of CT and MRI Reports for Hepatocellular Carcinoma Diagnosis","volume":"14","author":"M Flusberg","year":"2017","journal-title":"J Am Coll Radiol JACR"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00117-014-2763-y","article-title":"Response criteria for malignant melanoma: RECIST and irRC","volume":"55","author":"J Spiro","year":"2015","journal-title":"Radiologe"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"EA Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s40134-016-0178-4","article-title":"RECIST 1.1, irRECIST 1.1, and mRECIST: How to Do","volume":"4","author":"J Henze","year":"2016","journal-title":"Curr Radiol Rep"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"052","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma","volume":"30","author":"R Lencioni","year":"2010","journal-title":"Semin Liver Dis"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e052294","DOI":"10.1136\/bmjopen-2021-052294","article-title":"RECIST 1.1 versus mRECIST for assessment of tumour response to molecular targeted therapies and disease outcomes in patients with hepatocellular carcinoma: A systematic review and meta-analysis","volume":"12","author":"H Yu","year":"2022","journal-title":"BMJ Open"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e212","DOI":"10.1016\/j.ejrad.2012.12.009","article-title":"Modified RECIST to assess tumor response after transarterial chemoembolization of hepatocellular carcinoma: CT-pathologic correlation in 178 liver explants","volume":"82","author":"I Bargellini","year":"2013","journal-title":"Eur J Radiol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1007\/s00261-018-1464-9","article-title":"Combination transarterial chemoembolization and microwave ablation improves local tumor control for 3- to 5-cm hepatocellular carcinoma when compared with transarterial chemoembolization alone","volume":"43","author":"AR Smolock","year":"2018","journal-title":"Abdom Radiol (NY)"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1055\/a-1212-5915","article-title":"LI-RADS in the year 2020 \u2013 Are you already using it or still considering?","volume":"193","author":"KI Ringe","year":"2021","journal-title":"Fortschr R\u00f6ntgenstr"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/j.acra.2015.08.016","article-title":"Clinical and Imaging Follow-up Practices after Transarterial Therapy for Primary and Secondary Hepatic Malignancies: Results of an Online Survey","volume":"22","author":"RC Gaba","year":"2015","journal-title":"Acad Radiol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s00261-020-02598-0","article-title":"Imaging of hepatocellular carcinoma: A pilot international survey","volume":"46","author":"A Tang","year":"2021","journal-title":"Abdom Radiol (NY)"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"e143","DOI":"10.1016\/S1470-2045(17)30074-8","article-title":"iRECIST: Guidelines for response criteria for use in trials testing immunotherapeutics","volume":"18","author":"L Seymour","year":"2017","journal-title":"Lancet Oncol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1586\/17474124.2015.959929","article-title":"Evolution from WHO to EASL and mRECIST for hepatocellular carcinoma: Considerations for tumor response assessment","volume":"9","author":"MN Kim","year":"2015","journal-title":"Expert Rev Gastroenterol Hepatol"}],"container-title":["R\u00f6Fo - Fortschritte auf dem Gebiet der R\u00f6ntgenstrahlen und der bildgebenden Verfahren"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2438-1670.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T22:39:42Z","timestamp":1755643182000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2438-1670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,23]]},"references-count":24,"journal-issue":{"issue":"09","published-online":{"date-parts":[[2025,8,19]]},"published-print":{"date-parts":[[2025,9]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2438-1670","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1438-9029","1438-9010"],"issn-type":[{"value":"1438-9029","type":"print"},{"value":"1438-9010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,23]]}}}